With the US deadline for pharmaceutical serialisation just around the corner and the EU regulations due to come into force in 2019, track and trace implementation is set to be a major topic for 2017.

If the industry does not get to grips with serialisation soon, it could be too late.

Our Executive Vice President – Corporate Development, Mark Quick, spoke to European Pharmaceutical Magazine about what 2017 has in store for the industry and the impact that serialisation will have on unprepared marketing authorisation (MA) holders and contract manufacturers.

Read the full article here

EMP Magazine, Feb 17, 2017